Valuation: Adocia

Market Cap 83.74M 95.84M 76.9M 71.71M 136M 9.12B 138M 926M 359M 4.48B 360M 352M 15.42B P/E 2026 *
17.3x
P/E 2027 * -10.6x
Enterprise Value 34.98M 40.03M 32.12M 29.95M 56.78M 3.81B 57.74M 387M 150M 1.87B 150M 147M 6.44B EV / Sales 2026 *
0.91x
EV / Sales 2027 * -0.52x
Free-Float
89.7%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 55 11/05/2023
Director of Finance/CFO - 23/09/2024
Chief Tech/Sci/R&D Officer - 01/12/2014
Director TitleAgeSince
Director/Board Member 55 19/04/2013
Chairman 80 24/02/2012
Director/Board Member 58 18/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 92.84M
+3.98%+10.23%+73.54%+132.19% 56.21B
-3.12%+5.11%+71.57%+94.67% 55.38B
+3.70%+8.23%-10.02%-9.65% 23.75B
+3.23%+4.77%+11.41%+427.47% 23.19B
+3.64%+10.54%+39.81%-4.50% 18.14B
+4.11%+8.89%+44.60%-27.73% 16.84B
+2.57%+20.26%+181.98%+355.99% 15.86B
+2.65%+3.25%+24.06%+187.30% 13.56B
+7.20%+10.70%+42.91% - 12.97B
Average +2.83%+7.25%+53.32%+144.47% 26.21B
Weighted average by Cap. +2.23%+6.09%+56.66%+134.54%

Financials

2026 *2027 *
Net sales 38.39M 43.93M 35.25M 32.87M 62.32M 4.18B 63.37M 424M 164M 2.05B 165M 161M 7.07B 14.75M 16.88M 13.55M 12.63M 23.95M 1.61B 24.35M 163M 63.21M 788M 63.39M 62.01M 2.72B
Net income 3.98M 4.55M 3.65M 3.41M 6.46M 433M 6.56M 43.96M 17.04M 212M 17.09M 16.71M 732M -8.01M -9.17M -7.35M -6.86M -13M -873M -13.22M -88.54M -34.31M -428M -34.41M -33.67M -1.47B
Net Debt -48.77M -55.81M -44.78M -41.76M -79.17M -5.31B -80.5M -539M -209M -2.61B -210M -205M -8.98B -91.47M -105M -84M -78.33M -148M -9.97B -151M -1.01B -392M -4.89B -393M -385M -16.84B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-